Ginseng

Ginseng (Panax ginseng) is a slow-growing perennial of the Araliaceae family, native to the deciduous forest understorey of Korea, northeast China, and the Russian Far East. The fleshy aromatic root, often gnarled into a shape that resembles a human figure, has been the most prized item of East Asian materia medica for several thousand years. Two species share the genus name Panax: P. ginseng (Asian ginseng) and P. quinquefolius (American ginseng). They carry different ratios of bioactive ginsenosides and are used differently in classical Chinese practice (warming for Asian, cooling for American).

The main bioactive group is a family of triterpenoid saponins called ginsenosides, with more than twenty individual ginsenosides described and the major markers Rb1, Rg1, and Re used to characterise extracts. The European Medicines Agency Committee on Herbal Medicinal Products (EMA HMPCEuropean Medicines Agency, Committee on Herbal Medicinal Products (HMPC)) holds a Community herbal monograph for Panax ginseng root, with a traditional-use indication only (Panax ginseng C.A.Mey., Revision 1, 2024) for the relief of symptoms of mental and physical fatigue and of asthenia such as fatigue and weakness. The monograph carries no well-established-use indication. In a food-supplement context this traditional invigoration framing is appropriate. Ginseng is not the same plant as Siberian ginseng (Eleutherococcus senticosus), which belongs to a different genus despite the shared common name.

Ginseng has been used in Chinese medicine for at least two thousand years and is described in classical Chinese materia medica as a warming, tonifying root for restoration of vitality and recovery from depletion. In Traditional Chinese Medicine the root is classified as warming and supplementing, used in formulas for convalescence and declining capacity for work. The shape of the gnarled root, often resembling a human figure with arms and legs, gave rise to the Chinese name Renshen (man-root) and to centuries of folk valuation of particularly humanoid specimens. Wild-grown roots from the mountains of northeast Asia have historically commanded prices similar to precious metals.

Carl Linnaeus gave the genus its scientific name Panax in the eighteenth century, derived from the Greek panakeia (a cure-all), the same root as the English word panacea. The root reached Europe through trade routes via Russia and was introduced into European herbal practice through monastic and court physicians; it never fully integrated into Austrian or central European Hausmittel tradition but became a recognised import herb. The Commission E monograph in Germany lists Panax ginseng root with a positive assessment as a tonic for invigoration and fortification in times of fatigue and declining capacity for work and concentration, and during convalescence. The EMA HMPCEuropean Medicines Agency, Committee on Herbal Medicinal Products (HMPC) monograph for Ginseng radix (Panax ginseng C.A.Mey., Revision 1, 2024) finalised the European regulatory anchor as a traditional-use registration only, with a traditional-use indication for the relief of symptoms of asthenia such as fatigue and weakness and of mental and physical fatigue. The monograph carries no well-established-use indication.

The signature bioactives in Panax ginseng root are a family of triterpenoid saponins called ginsenosides. More than twenty individual ginsenosides have been described in the root; the major analytical markers are Rb1, Rg1, and Re, with characteristic ratios that distinguish Panax ginseng from Panax quinquefolius (American ginseng). The most widely studied standardised extract in clinical research is G115, which is calibrated to four per cent ginsenosides. Other constituents include polysaccharides, polyacetylenes, and small amounts of essential oil.

Mechanistic accounts describe ginseng as an adaptogen acting on the hypothalamic-pituitary-adrenal (HPA) axis, with proposed effects on cortisol regulation, on neurotransmitter signalling, and on energy metabolism. Different ginsenosides appear to have different and sometimes opposing effects in laboratory models (for example Rb1 with sedative profiles and Rg1 with more stimulating profiles), which makes a single unified mechanism harder to defend. These accounts draw on a mix of in-vitro work, animal studies, and small human trials, and the picture is not settled. The link between specific ginsenosides and any clinical effect in people is plausible but not firmly established. Ginseng is best read as a long-established East Asian tonic with a modest, mixed modern research base.

Modern clinical research on Panax ginseng is uneven. A 2010 Cochrane systematic review by Geng and colleagues looked at ginseng for cognitive function and reported mixed evidence with substantial heterogeneity between trials and methodological limitations; the review did not support a confident recommendation. Reay and colleagues published a series of smaller cognitive performance trials in the 2000s and 2010s suggesting acute effects on aspects of mental performance and subjective fatigue, but the trials are small in scale and the effect sizes modest. ESCOP and Commission E both summarise the traditional and modern evidence in their monographs, and the standardised extract G115 (calibrated to four per cent ginsenosides) is the product most often used in published trials.

Beyond fatigue and cognition, smaller bodies of work have looked at glycaemic control, immune function, and physical performance, with variable and not yet conclusive results. EFSA has not granted a permitted health claim for Panax ginseng. The EMA HMPCEuropean Medicines Agency, Committee on Herbal Medicinal Products (HMPC) monograph for Ginseng radix (Revision 1, 2024) is a traditional-use registration only and carries no well-established-use indication for asthenia; food-supplement copy uses the traditional-use framing for the relief of mental and physical fatigue. The honest summary is that ginseng has a long traditional record and a modest, mixed modern evidence base.

Forms and preparation

Most modern Panax ginseng products are standardised extracts in capsule or tablet form. The G115 extract (four per cent ginsenosides) is the most studied benchmark; other branded extracts vary in ginsenoside content and ratio, and a high-quality product declares the ginsenoside percentage and the marker ratios on the label. A processing distinction matters: white ginseng is the air-dried fresh root, while red ginseng is steamed and then dried, a treatment that changes the ginsenoside profile and is traditionally regarded as more warming. Tinctures, teas, and plain root powder also exist; root powder is bitter and most often taken as a decoction or in capsules. Take ginseng during the day rather than in the evening; the herb has a stimulating dimension for many people and can interfere with sleep when taken late. With food is the conservative default; some people tolerate it on an empty stomach but it can be mildly irritating to the digestion. Do not switch between branded extracts mid-course without comparing the declared ginsenoside content; the dose-equivalent of one product is not always the dose-equivalent of another. If you are buying loose root, the quality and age of the root strongly influence the ginsenoside load, so buy from a reputable source.

Dosage

In the research literature the typical daily dose of a standardised root extract is in the range of two hundred to four hundred milligrams per day, taken once in the morning or split between morning and lunchtime. For plain dried root the traditional daily amount is higher, typically one to three grams, prepared as a decoction or taken in capsule form. The EMA HMPC monograph supports use for short courses; continuous use beyond about three months is not recommended without a break, and the HMPC sets three months as a practical maximum duration before pausing and re-evaluating. Start low. Begin with the lower end of the range (two hundred milligrams of a standardised extract per day) for one to two weeks and see how you tolerate it before adjusting. Take it earlier in the day and not within several hours of bedtime. Plan a break after no more than three months of continuous use, as the EMA HMPC monograph indicates. Long-term continuous use is not well studied.